Employing Narrative Forms of Communication for Cervical Cancer Prevention Message

采用叙事形式传播宫颈癌预防信息

• 批准号: 7484807
• 负责人: Suellen Hopfer
• 金额: $ 3.78万
• 依托单位: PENNSYLVANIA STATE UNIVERSITY, THE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7484807
• 关键词: Employing; Narrative; Forms; Communication; Cervical

DESCRIPTION (provided by applicant): Cervical cancer remains a significant public health burden with an estimated 10,370 women diagnosed and 3,710 dying in 2007. A human papillomavirus (HPV) vaccine, Gardasil. approved in June 2006, has shown promise in reducing the incidence of high-risk HPV types 16 and 18, which are necessary though not sufficient causes of cervical cancer. Communication will play a key role in realizing the preventive potential of this vaccine. Health care providers have limited guidelines for how to effectively communicate about the HPV vaccine because research is just beginning to address this concern. The proposed study will address this need through a tri-phased process guided by a theoretical framework based on narrative theory of cancer communication (Kreuter et al., 2007), the theory of normative social behavior (Rimal & Real, 2005) and the story model (Pennington & Hastie, 1986). Formative research (in-depth interviews) will be conducted to identify determinants of vaccine acceptability and develop narratives (phase 1). Formative research findings and theory will inform health message design about the HPV vaccine and cervical cancer prevention (phase 2). Health messages will be piloted and subsequently tested in a clinical trial (phase 3). Specific aims of the proposed study include identifying determinants (attitudes, beliefs, and practices) of HPV vaccine acceptability among college women and developing an online narrative intervention for effective delivery of HPV vaccine information. These specific aims address the CDC mission to (a) reduce cervical cancer incidence and sexually transmitted infections (STIs) such as HPV, and (b) improve health literacy. Cervical cancer remains a significant public health burden with annual newly diagnosed case estimates at 10,370 and annual mortality rates at 3710. The human papillomavirus (HPV) vaccine Gardasil , released in June 2006, has the preventive potential to reduce cervical cancer incidence up to 70 percent, HPV, and costs related to cervical disease. The overall goal of the proposed research is to (a) identify effective, evidence-based communication strategies to increase utilization of the HPV vaccine among college age women and, (b) test a theory-based online narrative intervention that shows promise to improve health literacy.

描述（由申请人提供）： 宫颈癌仍然是一个重大的公共卫生负担，2007年估计有10 370名妇女被诊断出患有宫颈癌，3 710人死亡。 一种人乳头瘤病毒（HPV）疫苗，Gardasil。在2006年6月获得批准的新疫苗，在降低高危型HPV 16和18的发病率方面显示出了希望，这是宫颈癌的必要但不是充分的原因。传播将在实现这种疫苗的预防潜力方面发挥关键作用。卫生保健提供者对于如何有效地沟通HPV疫苗的指导方针有限，因为研究刚刚开始解决这一问题。所提出的研究将通过由基于癌症传播的叙事理论的理论框架指导的三阶段过程来解决这一需求（Kreuter等人，2007）、规范社会行为理论（Rennett &真实的，2005）和故事模型（彭宁顿& Hastie，1986）。将进行形成性研究（深入访谈），以确定疫苗可接受性的决定因素并制定叙述（第1阶段）。形成性的研究结果和理论将为HPV疫苗和宫颈癌预防（第2阶段）的健康信息设计提供信息。健康信息将进行试点，随后在临床试验（第3阶段）中进行测试。拟议研究的具体目标包括确定大学女性HPV疫苗可接受性的决定因素（态度，信仰和实践），并开发一种在线叙事干预措施，以有效提供HPV疫苗信息。这些具体目标涉及疾病预防控制中心的使命：（a）降低宫颈癌发病率和HPV等性传播感染（STI），以及（B）提高健康素养。宫颈癌仍然是一个重大的公共卫生负担，每年新诊断病例估计为10 370例，年死亡率为3 710例。2006年6月发布的人乳头瘤病毒（HPV）疫苗Gardasil具有预防潜力，可将宫颈癌发病率降低70%，HPV和与宫颈疾病相关的费用。拟议研究的总体目标是（a）确定有效的，以证据为基础的沟通策略，以增加大学年龄妇女对HPV疫苗的利用，（B）测试基于理论的在线叙事干预，显示出改善健康素养的希望。